Microbot Medical Inc. (NASDAQ: MBOT) stock spiked more than 150% on a massive 194 million share volume on a successful pre-clinical animal study for its LIBERTY surgical robotic system. Shares hit a ...
Limited Market Release (LMR) of the LIBERTY® System is on Schedule Building on Positive Customer Feedback and Growing Market ...
Hosted on MSN
FDA clears Microbot’s LIBERTY endovascular robot
The US Food and Drug Administration (FDA) has cleared Microbot’s LIBERTY, a single-use, remotely operated robotic system for peripheral endovascular procedures. Microbot completed the ACCESS-BVI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback